Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a gentler antibiotic beat the standard for a tough lung infection?

NCT ID NCT03236987

Recruiting now Disease control Sponsor: Centre Hospitalier Universitaire, Amiens Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two antibiotics, clarithromycin and azithromycin, for treating MAC lung infections, a serious bacterial lung disease. About 424 adults with MAC infection will receive one of the two drugs alongside standard treatments. The goal is to see if azithromycin works just as well but causes fewer side effects like liver problems or stomach upset.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Mycobacterium avium complex disease pneumonia pulmonary non-tuberculous mycobacterial infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG INFECTION MAC LUNG DISEASE

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU Amiens Picardie

    NOT_YET_RECRUITING

    Amiens, Picardie, 80054, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHU Angers

    RECRUITING

    Angers, 49933, France

  • Saint Joseph Hospital

    RECRUITING

    Marseille, 13000, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.